Adrian Kempe scores late, and the Kings beat the Lightning 2-1 for a 4-game winning streak

LOS ANGELES (AP) — Adrian Kempe broke a tie with 5:48 to play and the Los Angeles Kings beat the Tampa Bay Lightning 2-1 on Saturday night for their fourth consecutive victory.

Mikey Anderson scored in the first period and Darcy Kuemper made 34 saves for the Kings, who shut out Tampa Bay over the final 58 1/2 minutes. Los Angeles has won 12 of 16.

Captain Victor Hedman scored and Andrei Vasilevskiy stopped 19 shots for Tampa Bay, which has lost three straight games for the first time in two months.

Hedman, who was bloodied by a puck to the head Thursday at San Jose, scored just 70 seconds after the opening faceoff in Los Angeles. The star defenseman's powerful shot ramped off Anderson's stick and beat Kuemper for his fifth goal of the season.

Anderson answered several minutes later with a long shot through traffic for his career high-tying fifth goal.

Lightning: The NHL’s highest-scoring team is in a mini-slump with just four goals during its three-game skid.

Kings: They've earned a point in 14 of 16 games since late November. Kuemper was outstanding to lead a strong, physical defensive performance.

The winning goal was created by Alex Turcotte, who capitalized when Nick Perbix fell down while skating toward a pass from Brayden Point in the Lightning's end. Turcotte outskated Perbix to the puck before dropping a pass to Kempe, who fired home his 19th goal.

Lewis returned from a 12-game injury absence and played in his 1,000th career NHL game. The 37-year-old forward won the Stanley Cup with Los Angeles in 2012 and 2014, and he returned to the Kings last season after three years away.

The Lightning take the I-10 freeway to the I-5 south to face the Ducks on Sunday night. The Kings get three days off before hosting the Flames on Wednesday night.

AP NHL: https://apnews.com/NHL

Tampa Bay Lightning goaltender Andrei Vasilevskiy, right, deflects a shot as Los Angeles Kings left wing Warren Foegele, center, is shoves to the ice by defenseman Erik Cernak during the second period of an NHL hockey game, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

Tampa Bay Lightning defenseman Darren Raddysh, left, moves the puck while Los Angeles Kings left wing Warren Foegele puts pressure on him during the second period of an NHL hockey game, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

Tampa Bay Lightning goaltender Andrei Vasilevskiy makes a glove safe during the second period of an NHL hockey game against the Los Angeles Kings, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

Los Angeles Kings goaltender Darcy Kuemper makes a glove save during the first period of an NHL hockey game against the Tampa Bay Lightning, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

Los Angeles Kings left wing Kevin Fiala, left, and Tampa Bay Lightning right wing Mitchell Chaffee scuffle during the first period of an NHL hockey game, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

Tampa Bay Lightning center Luke Glendening, left, and Los Angeles Kings defenseman Vladislav Gavrikov fall as they vie for the puck during the first period of an NHL hockey game, Saturday, Jan. 4, 2025, in Los Angeles. (AP Photo/Mark J. Terrill)

NEWARK, Del.--(BUSINESS WIRE)--Jan 15, 2026--

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/

The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements.

“Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution to support the growing needs of our customer’s clinical trial portfolios and the evolving expectations of regulatory authorities worldwide.”

“Oracle Argus provides QPS Holdings, LLC with a trusted, globally recognized drug safety platform that supports compliance with stringent pharmacovigilance standards and regulations, while streamlining end-to-end safety operations and insights at scale,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With our industry-leading solutions, QPS Holdings, LLC can further transform and elevate its safety case management for customers worldwide.”

The deployment of Oracle Argus will enable QPS to:

As the demand for innovative therapies continues to rise, CROs play a critical role in managing both development speed and patient safety. By leveraging the Oracle Argus platform, QPS is well-positioned to deliver on its mission to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services.

###

ABOUT QPS HOLDINGS, LLC

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and India. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, PBMC processing, central safety labs, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I/II clinical units, and multi-site clinical research services. For more information, visit http://www.qps.com or email info@qps.com.

ABOUT ORACLE ARGUS

Oracle Argus is an industry-leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle has been a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/life-sciences/safety-solutions/argus-safety-case-management/. Trademarks: Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation.

Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC.